A Study of TAK-279 in Adults With or Without Kidney Problems
NCT05992155
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Healthy Volunteers
Interventions
DRUG:
TAK-279
Sponsor
Takeda